Identifying Potential Biomarkers and Clinical Trial Outcomes for Future Clinical Trials for SLC13A5 Deficiency
dc.contributor.advisor | Simecka, Jerry W. | |
dc.contributor.committeeMember | Cihlar, Jennifer C. | |
dc.creator | Cooper, Sydney | |
dc.date.accessioned | 2023-04-04T20:32:06Z | |
dc.date.available | 2023-04-04T20:32:06Z | |
dc.date.issued | 2022-12 | |
dc.format.mimetype | application/pdf | |
dc.identifier.uri | https://hdl.handle.net/20.500.12503/32099 | |
dc.language.iso | en | |
dc.subject | SLC13A5 deficiency | |
dc.subject | gene therapy | |
dc.subject | rare disease | |
dc.subject.mesh | Genetic Therapy | |
dc.subject.mesh | Rare Diseases | |
dc.subject.mesh | Biomarkers | |
dc.title | Identifying Potential Biomarkers and Clinical Trial Outcomes for Future Clinical Trials for SLC13A5 Deficiency | |
dc.type | Thesis | |
dc.type.material | text | |
thesis.degree.department | School of Biomedical Sciences | |
thesis.degree.discipline | Clinical Research Management | |
thesis.degree.grantor | University of North Texas Health Science Center at Fort Worth | |
thesis.degree.name | Master of Science |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2022_12_sbs_Cooper_Sydney_practicum.pdf
- Size:
- 346.37 KB
- Format:
- Adobe Portable Document Format
- Description: